To further analyze the clinical impact of S100A7/cPLA2 signaling in modulating the host immunosuppressive response, we investigated the correlation of these two proteins with the abundance of tumor-promoting CD163+ M2-TAMs using TMAs of invasive breast cancer patients. This evidence concerns the gene PLA2G4A and invasive breast carcinoma.